Listed in the order our main ranking sets, with each provider's price line printed exactly as they publish it.
CoreAge Rx
Doctor-reviewed tirzepatide with one flat price and built-in human support.
Price as published
$149 / month, flat across all dose levels
▸How the program works, and its trade-offs
U.S.-licensed clinicians review an online intake; the tirzepatide protocol is filled by a 503A compounding pharmacy. Pricing is a single flat $149/month that does not change as your dose is titrated up, every plan includes 1:1 nurse and registered-dietitian consults, and you are refunded automatically if you are not approved for treatment.
In its favour
- Flat $149/month that stays the same across every dose level — no escalation surcharge as you titrate up
- Doctor-reviewed protocols filled by a 503A compounding pharmacy
- Included 1:1 support from nurses and registered dietitians
- Automatic refund if you are not approved for treatment
Against it
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound) — see our evidence guide
- Single-medication focus rather than a broad telehealth catalog
Ageless
Broad compounded storefront pairing $169/month injectable tirzepatide with a rare oral-drop option — plus NAD+, sermorelin, and TRT under one roof.
$169/mo injectable
Compounded
Price as published
Compounded injectable tirzepatide $169/month; oral tirzepatide drops $249/month; compounded semaglutide from $119/month (advertised prices are floors, finalized after clinical review)
▸How the program works, and its trade-offs
Fully online telehealth storefront (Try Ageless) built around one of the broadest compounded menus in the category: injectable tirzepatide at $169/month, an oral tirzepatide-drops option at $249/month, and compounded semaglutide from $119/month, alongside adjacent longevity and hormone lines (NAD+, sermorelin, low-dose naltrexone, methylene blue, and TRT). A licensed clinician reviews an online intake and, where appropriate, the protocol is filled by 503A/503B partner pharmacies and shipped discreetly; no insurance is taken and Klarna/Affirm financing is offered. The headline prices are floors that can rise after clinical review, and Ageless does not publish which states it serves.
In its favour
- Unusually broad compounded menu under one roof — injectable and oral tirzepatide plus semaglutide, with NAD+, sermorelin, and TRT alongside
- Transparent, low headline tirzepatide pricing ($169/month injectable) with no insurance required and Klarna/Affirm financing
- Rare oral tirzepatide-drops pathway for patients who want to avoid injections
- 100% online with licensed-clinician review, discreet delivery, and clear upfront compounded/not-FDA disclaimers
Against it
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound) — quality depends on the partner pharmacies
- Oral tirzepatide drops lack the robust absorption and efficacy evidence of injectables
- No published list of states served and no named legal entity or medical group — a transparency gap
- Advertised prices are floors finalized after clinical review, and the very broad storefront has a thin public track record
Found
Established, physician-designed weight care with a broad formulary — real brand-name Zepbound/Mounjaro alongside compounded tirzepatide, paired with coaching.
From $99/mo (varies)
Compounded
Price as published
Pricing varies by path and state: compounded GLP-1 entry as low as $99/month (realistic compounded tirzepatide roughly $299–$399/month); brand-name pathway adds a membership of about $39/month
▸How the program works, and its trade-offs
Founded in 2019, Found is an established weight-care platform with 250k+ members and one of the broadest formularies in telehealth. Obesity-medicine clinicians review an online intake and prescribe from a wide menu — compounded tirzepatide, the FDA-approved brand-name products (Zepbound and Mounjaro), brand and compounded semaglutide, and oral Rybelsus — matched to each patient. Medication is paired with behavioral coaching, an app, a member community, and insurance navigation. Available in all 50 states with HSA/FSA accepted. Pricing is layered rather than flat: a compounded GLP-1 entry point advertised as low as $99/month (the cheapest tiers require a 3–12 month prepay), realistic compounded tirzepatide around $299–$399/month, and a brand-name pathway that stacks a membership of roughly $39/month on top of the medication; cost and coverage vary by state and plan.
In its favour
- Established since 2019 and sizable (250k+ members), with obesity-medicine clinicians — a longer track record than most compounded-only startups
- Broad formulary including the real FDA-approved brand-name products (Zepbound and Mounjaro), not only compounded tirzepatide
- Behavioral coaching, app, and member community paired with the medication
- Insurance navigation plus HSA/FSA accepted, available in all 50 states
Against it
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
- Layered pricing — the cheapest compounded rate requires a 3–12 month prepay
- The brand-name pathway stacks a separate membership fee (about $39/month) on top of the medication
- Cost and coverage vary by state and plan, so there is no single flat monthly figure
Gala Health
Low-cost compounded tirzepatide shipped to all 50 states, with a brand-name path if you want it.
$179/mo compounded
Compounded
Price as published
Compounded tirzepatide $179/month (microdose $149/month; 3-month plans from $199); brand Ozempic available at $1,299
▸How the program works, and its trade-offs
Telehealth weight program from Gala (AI Coaching Inc). A licensed prescriber reviews an online intake and, where appropriate, compounded tirzepatide ships for $179/month, with a lower $149/month microdose tier and 3-month bundles starting at $199. Uniquely for a compounded provider at this price, Gala is available in all 50 states and also offers a brand-name pathway (Ozempic) for patients who specifically want the FDA-approved product, plus HRT and menopause care under the same roof.
In its favour
- Low compounded-tirzepatide entry price at $179/month, with an even cheaper $149 microdose tier
- Available in all 50 states — broader coverage than most compounded-only startups
- Offers a brand-name pathway (Ozempic) alongside compounded options
- HRT and menopause care available for patients wanting adjacent treatment
Against it
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
- The brand-name Ozempic option is very expensive at $1,299
- No oral tirzepatide pathway yet
- Newer operator with a shorter track record than established telehealth platforms
Trimi
Compounded tirzepatide on a single nationwide membership, shipped fast to all 50 states.
Price as published
Compounded tirzepatide $229/month on one membership — no separate medication-plus-membership stack
▸How the program works, and its trade-offs
Direct-to-patient telehealth built around one membership rather than a medication fee bolted onto a second subscription. A U.S.-licensed prescriber reviews an online intake and, if appropriate, compounded tirzepatide ships free to all 50 states — typically within about a day of approval. Semaglutide is offered on the same membership, so the tirzepatide price is the all-in monthly figure rather than a base price plus surprise add-ons.
In its favour
- One straightforward membership covering the visit, medication, and free nationwide shipping — no separate stacked fee
- Ships to all 50 states, usually within roughly 24 hours of prescriber approval
- Single-membership model keeps the true monthly total predictable as you titrate
Against it
- At $229/month it costs more than CoreAge's flat $149 for the same molecule
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
- The dispensing compounding pharmacy is not publicly named on the site
- Injectable only — no oral or brand-name pathway
Enhance MD
Transparent tiered compounded tirzepatide — microdose, standard, and combination options with included labs.
$280/mo compounded
Compounded
Price as published
Compounded tirzepatide $280/month (microdose tirzepatide $169/month; sema+tirz combo $322/month; compounded semaglutide $212/month, first month $112)
▸How the program works, and its trade-offs
Compounded-only telehealth program with an unusually transparent, published price ladder: standard compounded tirzepatide at $280/month, a lower $169/month microdose tirzepatide tier, a semaglutide-plus-tirzepatide combination at $322/month, and compounded semaglutide at $212/month ($112 the first month). Pricing is dose-flat within each tier, provider care and 6-month lab testing are included, and NAD+ is offered as an adjacent longevity option.
In its favour
- Transparent, published tiered pricing including microdose and a sema+tirz combination
- Dose-flat within each tier — no surcharge as you titrate up
- Included provider care and 6-month lab testing
- NAD+ available as an adjacent longevity offering
Against it
- Compounded only — no FDA-approved brand or oral tirzepatide pathway
- Higher entry price ($280/month standard tirzepatide) than CoreAge's flat $149
- States served are not published on the site
- The standard tier costs more than several rivals for the same molecule
yourEra
Transparent compounded tirzepatide with both molecules and a broad longevity menu, shipped nationwide — priced in the mid-market.
$299/mo compounded
Compounded
Price as published
Compounded tirzepatide $299/month (weekly injectable); compounded semaglutide from $199/month; NAD+ from $249/month; optional yourEra Optimum coaching membership +$149/month
▸How the program works, and its trade-offs
"A New Era of Personalized Health" — yourEra is a compounded-only telehealth brand that publishes its prices openly, a genuine plus in a category where many competitors hide cost behind a quiz. A licensed clinician reviews an online intake and, where appropriate, compounded tirzepatide ships as a weekly injectable at $299/month, with compounded semaglutide from $199/month on the same platform. The broader menu adds NAD+ from $249/month and microdosing protocols from $179/month, plus an optional yourEra Optimum membership (+$149/month) that bundles 1:1 coaching, a nutritionist, at-home lab draws, and wearables. yourEra markets a 50-state licensed-clinician network with no insurance required and HSA/FSA accepted; the 50-state reach and efficacy claims are self-reported.
In its favour
- Transparent, publicly listed pricing on the site — many compounded competitors hide the price behind a quiz
- Both semaglutide and tirzepatide (not single-drug), plus a broad menu — NAD+, microdosing, and an optional coaching/nutritionist/labs bundle
- Markets 50-state clinician access with no insurance required and HSA/FSA accepted
Against it
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound), and compounding availability can tighten as brand shortages resolve
- Mid-market pricing at $299/month — above the cheapest compounders (~$99–$150)
- No brand-name and no oral pathway — injectable only
- Thin independent footprint with few third-party reviews; the 50-state and efficacy claims are self-reported
Telos Rx
Compounded injectable, oral, and microdosed tirzepatide from a LegitScript-certified telehealth, with a low annual entry price.
From $99/mo annual
Compounded
Price as published
Compounded tirzepatide from $99/month on an annual plan (microdose from $49/month on a 12-month plan); short plans $145/$199/$399 first month
▸How the program works, and its trade-offs
LegitScript-certified, HIPAA-compliant compounded telehealth with an unusually broad tirzepatide menu: compounded injectable, oral, and microdosed tirzepatide, plus compounded semaglutide. U.S. providers and licensed pharmacies review an online intake; published GLP-1 pricing starts at $49/month for microdosed tirzepatide on a 12-month plan and $99/month for tirzepatide on an annual plan, with shorter first-month plans at $145/$199/$399. HSA/FSA is accepted with free 48-hour shipping. The broader catalog also spans semaglutide, PT-141, intranasal NAD+, recovery peptides, and HRT, though pricing outside the GLP-1 menu is not published and the states served are not listed.
In its favour
- Multiple tirzepatide formats — compounded injectable, oral, and microdosed — a rare combination in one program
- LegitScript-certified and HIPAA-compliant, with U.S. providers and licensed pharmacies
- Low published entry price on annual plans (from $99/month tirzepatide; from $49/month microdosed), with HSA/FSA accepted and free 48-hour shipping
- Broad catalog beyond GLP-1 (semaglutide, PT-141, intranasal NAD+, recovery peptides, HRT)
Against it
- Every formulation is compounded — not the FDA-approved branded product (Mounjaro / Zepbound)
- The lowest headline prices require a 6- to 12-month commitment; short plans run $145/$199/$399 for the first month
- Pricing is opaque outside the GLP-1 menu, and the list of states served is not published
- No named clinicians and thin third-party reviews
Direct Meds
One of the few programs offering oral/sublingual tirzepatide alongside injectable, on an all-inclusive fee.
~$224/mo sublingual
Compounded
Price as published
Compounded tirzepatide ~$224/month sublingual or ~$399/month injectable; semaglutide ~$179–$297/month (intro promo ~$147) — company-stated, not independently verified
▸How the program works, and its trade-offs
Compounded-only telehealth pharmacy (launched 2024) that is unusual in offering an oral/sublingual tirzepatide route in addition to standard injectable, plus compounded semaglutide. Fees are described as all-inclusive with no separate membership. The figures here are stated by the company rather than confirmed on a live public price page, and the brand operates across multiple domains, so we present the numbers with that caveat rather than as independently verified.
In its favour
- Rare oral/sublingual tirzepatide option in addition to injectable
- All-inclusive pricing with no separate membership fee
- Offers both tirzepatide and semaglutide molecules
Against it
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
- Pricing is company-stated and could not be independently verified on a live page
- Newer operator (2024) with an ambiguous footprint across multiple domains
- States served are not disclosed
HealthRX
LegitScript-certified physician-supervised telehealth with a rare oral tirzepatide tablet alongside injectable.
~$189/mo injectable (company-stated)
Compounded
Price as published
Company-stated: compounded GLP injectable ~$189/month, oral GLP tablet ~$239/month, GLP+GIP ~$349/month; brand pass-through ~$1,299 — not independently verified
▸How the program works, and its trade-offs
Physician-supervised telehealth for medical weight loss that is LegitScript-certified (#50087439) — a genuine third-party trust signal that most compounded startups lack. A U.S. board-certified physician reviews an online intake and, where appropriate, compounded tirzepatide (and semaglutide) is filled by a licensed U.S. 503A pharmacy with transparent monthly pricing and no insurance required. HealthRX is unusual in offering an oral GLP tablet in addition to the standard injectable. Company-stated tiers run about $189/month for the compounded GLP injectable, ~$239/month for the oral tablet, and ~$349/month for a GLP+GIP option, with a brand pass-through option quoted around $1,299; those figures are stated by the company rather than confirmed on a live public price page, so we present them with that caveat.
In its favour
- LegitScript-certified (#50087439) — a genuine third-party trust signal most compounded providers lack
- Physician-supervised, with a licensed U.S. 503A compounding pharmacy
- Offers tirzepatide, semaglutide, and a rare oral GLP tablet alongside injectable
- Transparent monthly pricing with no insurance required
Against it
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
- Several tiers are company-stated and could not be independently verified on a live public page
- Brand tiers are an expensive pass-through (~$1,299)
- Number of states served is not published
Sprout Health
LegitScript-certified compounded tirzepatide from $199/month with a real brand-name Wegovy/Zepbound path and a low-friction, no-labs signup.
From $199/mo compounded
Compounded
Price as published
Compounded tirzepatide from $199/month; compounded semaglutide from $149/month; a brand-name Wegovy/Zepbound pathway is also offered
▸How the program works, and its trade-offs
Sprout Health is a LegitScript-certified telehealth weight program. A licensed prescriber reviews an online intake and, where appropriate, compounded tirzepatide ships from $199/month as a weekly injectable, with compounded semaglutide from $149/month on the same platform. Unusually for a low-cost compounder, Sprout also offers a genuine brand-name Wegovy/Zepbound pathway for patients who specifically want an FDA-approved product. The signup is deliberately low-friction — often no labs and no separate video visit are required. The trade-offs are real: the program does not name a medical director, that low-friction model means thinner clinical oversight, state availability is gated behind a quiz rather than published upfront, and the tirzepatide itself is compounded (503A) and not FDA-approved.
In its favour
- LegitScript-certified — a genuine third-party trust signal many compounded startups lack
- Offers a real brand-name Wegovy/Zepbound pathway alongside compounded tirzepatide, uncommon for a low-cost compounder
- Transparent compounded pricing from $199/month tirzepatide (compounded semaglutide from $149/month)
- Low-friction signup — often no labs and no separate video visit required
Against it
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
- No named medical director, and the low-friction model (often no labs or visit) means thinner clinical oversight
- Injectable only — no oral tirzepatide pathway
- State availability is quiz-gated rather than published, and $199/month is above the cheapest flat compounders
Bodybuilding Health+
The Bodybuilding.com fitness brand's new compounded arm — value-priced tirzepatide bundles down to $139/month, alongside semaglutide, NAD+, sermorelin, and peptides.
$139/mo (12-mo bundle)
Compounded
Price as published
Compounded tirzepatide $209 first month (reg. $319), dropping to $179/mo on the 3-month plan and $139/mo on the 12-month plan; compounded semaglutide from $139/mo; all bundles paid upfront
▸How the program works, and its trade-offs
Bodybuilding Health+ is the compounded-telehealth arm of the Bodybuilding.com brand, operated by Dynamo Group LLC (Boca Raton, FL) and launched around April 2026. An online medical evaluation is reviewed by an independent licensed provider, and where appropriate a U.S.-registered compounding pharmacy fills the prescription. Its tirzepatide line is the on-thesis draw: publicly listed at $209 for the first month (reg. $319), then $179/month on the 3-month plan and $139/month on the 12-month plan, with compounded semaglutide from $139/month on the same platform — genuinely competitive pricing carried by a recognizable fitness brand. The broader menu adds NAD+, sermorelin, ED treatment, and a deep peptide catalog under one login. The tradeoffs are real: every GLP-1 here is compounded and not FDA-approved, the operator is brand-new with a thin, mixed third-party review record, bundle pricing is paid upfront, and prescription products are final sale.
In its favour
- Value-priced compounded tirzepatide bundles — $139/month on the 12-month plan (from $209 the first month), undercutting most mid-market compounders
- Transparent GLP-1 pricing shown publicly on the site, with compounded semaglutide also from $139/month
- Backed by the recognizable Bodybuilding.com brand and a broad menu (NAD+, sermorelin, ED, peptides) under one login
- Standard telehealth flow: online intake reviewed by an independent licensed provider, free until you are approved
Against it
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
- Brand-new operator (Dynamo Group LLC, launched ~April 2026) with a thin, mixed third-party review record
- Lowest prices require a large upfront prepay, and prescription products are final sale — no refunds for change of mind or results
- Pharmacy and provider network are not named on the consumer pages, and we could not verify a LegitScript certification
Mochi Health
Compounded tirzepatide with dietitian-led coaching, priced on top of a membership.
$199/mo + $79/mo membership
Compounded
Price as published
Compounded tirzepatide +$199/mo, plus membership ($39 first month, then $79/mo)
▸How the program works, and its trade-offs
Membership-based telehealth weight-care program. The compounded tirzepatide medication is billed at $199/month on top of a separate membership that buys unlimited access to a physician and dietitian, nutrition-coaching sessions, and 24/7 support.
In its favour
- Unlimited access to a physician and registered dietitian, plus nutrition coaching
- Compounded injectable tirzepatide available with flexible 1-, 3-, 6-, and 12-month terms
Against it
- Stacked cost: the $79/month membership is charged on top of the $199/month medication
- The membership renews after the promotional first month, raising the true monthly total
- Total monthly outlay runs well above CoreAge's flat $149 once the membership renews
Eden
Compounded tirzepatide at a low headline price, billed on top of a recurring membership.
$199/mo + $99/mo membership
Compounded
Price as published
Compounded tirzepatide $199/mo medication, plus Eden Membership ($39 first month, then $99/mo)
▸How the program works, and its trade-offs
Fully online intake with a licensed provider; compounded tirzepatide is shipped to your door for $199/month. The advertised price covers medication only — an active Eden Membership is required and billed separately, and renews at $99/month after the first month.
In its favour
- Entirely online with free shipping and a broad telehealth catalog
- Low promotional membership price for the first month
Against it
- Stacked cost: the membership ($99/month after the first month) is charged on top of the $199/month medication
- Membership is required to access a prescription and does not guarantee one
- Total monthly outlay can exceed CoreAge once the membership renews
Henry Meds
Compounded tirzepatide bundled into one all-in monthly fee — no separate membership.
From $179/mo all-in
Compounded
Price as published
Compounded GLP-1 medication starts at $179/month, all-in (provider visit, medication, supplies, and shipping included)
▸How the program works, and its trade-offs
Telehealth weight-management program that bundles the provider visit, medication, supplies, ongoing care, and shipping into a single monthly fee — there is no separate membership charge. The price varies by treatment plan and dose; the program's GLP-1 medication starts at $179/month. Injectable refills typically ship every 45 days.
In its favour
- Single all-in monthly fee with no separate membership stacked on top
- Provider visit, medication, supplies, ongoing care, and shipping included in the quoted price
Against it
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
- Quoted price is a starting figure that rises with higher doses and certain plans
- Compounded GLP-1 programs operate in a contracting, enforcement-heavy regulatory space post-shortage
Shed (ShedRx)
Compounded tirzepatide from a telehealth platform with unlimited follow-ups and coaching.
Price as published
Pricing varies — published on signup; medication plus included follow-ups and health coaching
▸How the program works, and its trade-offs
Telehealth program offering compounded injectable tirzepatide with unlimited follow-up appointments, health coaching, and portal access. Shed does not publish a confirmable monthly price on its public pages — the figure is shown during the signup flow — so we list it as varying rather than state a number we could not verify.
In its favour
- Unlimited follow-up appointments and health coaching included with membership
- Compounded injectable tirzepatide available through an online platform
Against it
- No confirmable monthly price published on the public site — pricing is shown only during signup
- Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
- Compounded GLP-1 programs operate in a contracting, enforcement-heavy regulatory space post-shortage